Silo Pharma, Inc. (SILO)
USD 0.82
(-14.82%)
USD 0.82
(-14.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.22 Million | -3.49 Million | -2.27 Million | -1.15 Million | -794.32 Thousand | 272.63 Thousand |
| Net Income | -3.63 Million | -3.9 Million | 3.9 Million | -3.03 Million | -1.01 Million | -969.46 Thousand |
| Depreciation & Amortization | 90.06 Thousand | - | 107.97 Thousand | 578.92 Thousand | 61.87 Thousand | 17.55 Thousand |
| Deferred income taxes | -339.27 Thousand | - | -107.97 Thousand | -578.92 Thousand | -61.87 Thousand | - |
| Stock-based compensation | 104.19 Thousand | 156.04 Thousand | 191.69 Thousand | 1.18 Million | 177.96 Thousand | - |
| Change in working capital | 299.27 Thousand | -75.28 Thousand | 729.71 Thousand | -87.2 Thousand | -82.46 Thousand | -16.79 Thousand |
| Other non-cash items | 252.32 Thousand | 330.17 Thousand | -7.1 Million | 778.32 Thousand | 123.47 Thousand | 1.24 Million |
| Investing Cash Flow | -4.14 Million | 86.7 Thousand | 7.19 Million | 39 Thousand | 186.74 Thousand | -250 Thousand |
| Investments in PPE | -2.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -4.14 Million | - | - | - | -5197.00 | - |
| Sales/Maturities of investments | - | 66.7 Thousand | 7.02 Million | - | 191.93 Thousand | 727.49 Thousand |
| Other Investing Activities | - | 20 Thousand | 172 Thousand | 39 Thousand | - | -977.49 Thousand |
| Financing Cash Flow | -471.12 Thousand | 4.94 Million | 3.79 Million | 2.13 Million | 382.65 Thousand | 19.45 Thousand |
| Debt repayment | - | - | - | -35 Thousand | -47.34 Thousand | -2177.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -471.12 Thousand | - | - | - | - | -2872.00 |
| Common Stock Issuance | - | 4.94 Million | 3.79 Million | 2.11 Million | 110 Thousand | 24.5 Thousand |
| Other Financing Activities | -471.12 Thousand | - | - | 53.9 Thousand | 320 Thousand | 2177.00 |
| Accounts receivables | -3590.00 | -4800.00 | -1210.00 | -72.52 Thousand | -29.23 Thousand | - |
| Accounts payables | 339.27 Thousand | -53.72 Thousand | 291.05 Thousand | 72.52 Thousand | 29.23 Thousand | -12.71 Thousand |
| Inventory | -339.27 Thousand | 4800.00 | -24.96 Thousand | -15.06 Thousand | -129.39 Thousand | -26.97 Thousand |
| Other working capital | 302.86 Thousand | -21.56 Thousand | 464.83 Thousand | -72.13 Thousand | 46.92 Thousand | 22.88 Thousand |
| Cash at beginning of period | 11.36 Million | 9.83 Million | 1.12 Million | 111.75 Thousand | 336.67 Thousand | 294.59 Thousand |
| Cash at end of period | 3.52 Million | 11.36 Million | 9.83 Million | 1.12 Million | 111.75 Thousand | 336.67 Thousand |
| Capital Expenditure | -2.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.84 Million | 1.53 Million | 8.7 Million | 1.01 Million | -224.92 Thousand | 42.08 Thousand |
| Free Cash Flow | -3.22 Million | -3.49 Million | -2.27 Million | -1.15 Million | -794.32 Thousand | 272.63 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -931.77 Thousand | -801.66 Thousand | -1.05 Million | -3.63 Million | -660.16 Thousand | -1.01 Million |
| Depreciation & Amortization | - | - | 56.29 Thousand | 90.06 Thousand | - | - |
| Deferred income taxes | - | - | - | -339.27 Thousand | - | - |
| Stock-based compensation | - | - | 1414.00 | 104.19 Thousand | 26.75 Thousand | 71.78 Thousand |
| Change in working capital | 198.71 Thousand | -36.27 Thousand | 144.19 Thousand | 299.27 Thousand | -440.28 Thousand | 419.28 Thousand |
| Other non-cash items | 1259.00 | -98.31 Thousand | -4041.00 | 252.32 Thousand | 1862.00 | -28.08 Thousand |
| Investing Cash Flow | 954.27 Thousand | 97.59 Thousand | 4.42 Million | -4.14 Million | 1.25 Million | -3.82 Million |
| Investments in PPE | 3.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -44.65 Thousand | -52.79 Thousand | 6.31 Million | -4.14 Million | -114.68 Thousand | -4.34 Million |
| Sales/Maturities of investments | 998.93 Thousand | 150.38 Thousand | -1.89 Million | - | 1.37 Million | 517.82 Thousand |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.61 Million | -115.45 Thousand | -194.42 Thousand | -471.12 Thousand | -145.73 Thousand | -130.95 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -57.66 Thousand | -115.45 Thousand | -194.42 Thousand | -471.12 Thousand | -145.73 Thousand | -130.95 Thousand |
| Common Stock Issuance | 1.67 Million | - | - | - | - | - |
| Other Financing Activities | 3.00 | -115.45 Thousand | -471.12 Thousand | -471.12 Thousand | - | - |
| Accounts receivables | - | - | 3590.00 | -3590.00 | -1210.00 | -1197.00 |
| Accounts payables | - | 98.08 Thousand | 96.81 Thousand | 339.27 Thousand | -441.42 Thousand | 387.81 Thousand |
| Inventory | - | - | -3590.00 | -339.27 Thousand | 1210.00 | 1197.00 |
| Other working capital | -3090.00 | -134.36 Thousand | 47.37 Thousand | 302.86 Thousand | 1133.00 | 31.47 Thousand |
| Cash at beginning of period | 2.66 Million | 3.52 Million | 199.83 Thousand | 11.36 Million | 158.83 Thousand | 4.66 Million |
| Cash at end of period | 4.5 Million | 2.66 Million | 3.52 Million | 3.52 Million | 199.83 Thousand | 158.83 Thousand |
| Capital Expenditure | 3.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 1.00 | - | - | -1.00 |
| Net cash flow / Change in cash | 1.83 Million | -856.03 Thousand | 3.32 Million | -7.84 Million | 41 Thousand | -4.5 Million |
| Free Cash Flow | -731.8 Thousand | -838.17 Thousand | -910.01 Thousand | -3.22 Million | -1.07 Million | -549.96 Thousand |
COMPUPN
DIACABS
603687
LEU
AEX
300817